Cinnoline derivatives as human neutrophil elastase inhibitors

Abstract

Compounds that can effectively inhibit the proteolytic activity of human neutrophil elastase (HNE) represent promising therapeutics for treatment of inflammatory diseases. We present here the synthesis, structure–activity relationship analysis, and biological evaluation of a new series of HNE inhibitors with a cinnoline scaffold. These compounds exhibited HNE inhibitory activity but had lower potency compared to N-benzoylindazoles previously reported by us. On the other hand, they exhibited increased stability in aqueous solution. The most potent compound, 18a, had a good balance between HNE inhibitory activity (IC₅₀ value = 56 nM) and chemical stability (t_1/2 = 114 min). Analysis of reaction kinetics revealed that these cinnoline derivatives were reversible competitive inhibitors of HNE. Furthermore, molecular docking studies of the active products into the HNE binding site revealed two types of HNE inhibitors: molecules with cinnolin-4(1H)-one scaffold, which were attacked by the HNE Ser195 hydroxyl group at the amido moiety, and cinnoline derivatives containing an ester function at C-4, which is the point of attack of Ser195.

• Cinnoline
• human neutrophil elastase
• inhibitory activity

Declaration of interest

This work was supported in part by NIH IDeA Program COBRE Grant GM110732 (MTQ) and a USDA National Institute of Food and Agriculture Hatch project, and the Montana State University Agricultural Experiment Station.

Supplementary material available online

Supplementary material, Figures S1-S6.